| Schedule of Stock Based Compensation |
| | |
Number
of shares** | | |
Weighted
average exercise price** | | |
Weighted
average grant date FV** | |
| Balance as of December 31, 2023 | |
| - | | |
| - | | |
| - | |
| Granted | |
| 4,105 | | |
| 0.02385 | * | |
| 38.00 | |
| Cancelled/forfeited | |
| - | | |
| - | | |
| - | |
| Vested | |
| 4,105 | | |
| 0.02385 | * | |
| 38.00 | |
| Balance as of December 31, 2024 and 2025 | |
| - | | |
| - | | |
| - | |
| * | The weighted average exercise price of USD 0.02385 is calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. |
| ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| | |
Number
of shares*** | | |
Weighted
average exercise price*** | | |
Weighted
average grant date FV*** | |
| Balance as of December 31, 2023 | |
| - | | |
| - | | |
| - | |
| Granted of December 5, 2024 | |
| 48,000 | | |
| 0.000015 | * | |
| 92.00 | |
| Granted of December 31, 2024 | |
| 18,000 | | |
| 0.000015 | * | |
| 92.00 | |
| Cancelled/forfeited | |
| - | | |
| - | | |
| - | |
| Vested | |
| 66,000 | | |
| 0.000015 | * | |
| 92.00 | |
| Balance as of December 31, 2024 | |
| - | | |
| - | | |
| - | |
| * | The weighted average exercise price of USD 0.0000015 is calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. |
| ** | As of December 31, 2024, the Company recorded a prepaid balance of $1,081,000 relating to payments made to consultants, which was recognized as share-based compensation expenses during 2025. |
| *** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| | |
Number
of shares** | | |
Weighted
average exercise price** | | |
Weighted
average grant date FV** | |
| Balance as of December 31, 2024 | |
| - | | |
| - | | |
| - | |
| Granted of February 3, 2025 | |
| 43,000 | | |
| 0.000015 | * | |
| 90.00 | |
| Granted of December 5, 2025 | |
| 27,000 | | |
| 0.000015 | * | |
| 10.00 | |
| Cancelled/forfeited | |
| - | | |
| - | | |
| - | |
| Vested | |
| 70,000 | | |
| 0.000015 | * | |
| 90.00 | |
| Balance as of December 31, 2025 | |
| - | | |
| - | | |
| - | |
| | |
Number
of shares** | | |
Weighted
average exercise price** | | |
Weighted
average grant date FV** | |
| Balance as of December 31, 2024 | |
| - | | |
| - | | |
| - | |
| Granted of December 5, 2025 | |
| 130,000 | | |
| 0.00001 | * | |
| 10.00 | |
| Vested | |
| 130,000 | | |
| 0.00001 | * | |
| 10.00 | |
| Balance as of December 31, 2025 | |
| - | | |
| - | | |
| - | |
| * | The weighted average exercise price of USD 0.000015 and USD 0.00001 are calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. | | ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| | |
Number
of shares*** | | |
Weighted
average exercise price*** | | |
Weighted
average grant date FV*** | |
| Balance as of December 31, 2024 | |
| - | | |
| - | | |
| - | |
| Granted | |
| 1,112 | | |
| 0.0008993 | * | |
| 47.50 | |
| Cancelled/forfeited | |
| - | | |
| - | | |
| - | |
| Vested | |
| 1,112 | | |
| 0.0008993 | * | |
| 47.50 | |
| Balance as of December 31, 2025 | |
| - | | |
| - | | |
| - | |
| * | The weighted average exercise price of USD 0.0008993 is calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. | | | | | ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| | |
Number
of shares*** | | |
Weighted
average exercise price*** | | |
Weighted
average grant date FV*** | |
| Balance as of December 31, 2024 | |
| - | | |
| - | | |
| - | |
| Granted | |
| 16,000 | | |
| 0.0000625 | * | |
| 19.10 | |
| Cancelled/forfeited | |
| - | | |
| - | | |
| - | |
| Vested | |
| 4,000 | | |
| 0.0000625 | * | |
| 19.10 | |
| Balance as of December 31, 2025 | |
| 12,000 | | |
| 0.0000625 | * | |
| 19.10 | |
| * | The
weighted average exercise price of USD 0.0000625 is calculated by dividing the total exercise price of the granted shares by the total
number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective
exercise price and dividing the sum by the total number of shares granted. |
| ** | As
of December 31, 2025, the unrecognized share-based compensation is $229,200. |
| *** | The
number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect
the Company’s reverse share split on March 23, 2026. |
|
| Schedule of Share-Based Compensation |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| - | | |
| 155,990 | | |
| - | |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| 1,081,000 | ** | |
| 5,003,000 | | |
| - | |
| ** | As of December 31, 2024, the Company recorded a prepaid balance of $1,081,000 relating to payments made to consultants, which was recognized as share-based compensation expenses during 2025. |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| 4,140,000 | | |
| - | | |
| - | |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| 1,300,000 | | |
| - | | |
| - | |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| 52,779 | ** | |
| - | | |
| - | |
| * | The weighted average exercise price of USD 0.0008993 is calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. | | | | | ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| | |
2025 | | |
2024 | | |
2023 | |
| Share-based compensation | |
| 76,400 | ** | |
| - | | |
| - | |
| ** | As
of December 31, 2025, the unrecognized share-based compensation is $229,200. |
|
| Schedule of Shares Granted Under Share Incentive Plan |
The following is the maximum aggregate number of shares which may be issued pursuant to all awards under the 2023 Share Incentive
Plan:
| | |
Maximum*** | | |
Number
of shares granted*** | |
| | |
| | | |
| | |
| 2023 Share Incentive Plan | |
| 66,000 | | |
| 66,000 | |
| ** | As of December 31, 2024, the Company recorded a prepaid balance of $1,081,000 relating to payments made to consultants, which was recognized as share-based compensation expenses during 2025. |
| | |
Maximum** | | |
Number
of shares granted** | |
| | |
| | | |
| | |
| 2024 Share Incentive Plan | |
| 70,000 | | |
| 70,000 | |
| | |
Maximum** | | |
Number
of shares granted** | |
| | |
| | | |
| | |
| 2025 Share Incentive Plan | |
| 130,000 | | |
| 130,000 | |
| ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. | | * | The weighted average exercise price of USD 0.0008993 is calculated by dividing the total exercise price of the granted shares by the total number of shares granted. The total exercise price is determined by multiplying the number of shares in each grant by its respective exercise price and dividing the sum by the total number of shares granted. | | | | | ** | The number of shares, weighted average exercise price and weighted average grant date FV are presented on a retroactive basis to reflect the Company’s reverse share split on March 23, 2026. |
| ** | As
of December 31, 2025, the unrecognized share-based compensation is $229,200. |
|